Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (611-620 of 622) with videos related to

Pageof 63
Sort By:
Rheumatology (Oxford, England)|February 3, 2023
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveysParikshit Sen, Naveen R, Nazanin Houshmand, et al.
Rheumatology (Oxford, England)|April 21, 2023
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveysNaveen R, Parikshit Sen, Zoltán Griger, et al.
Rheumatology (Oxford, England)|July 28, 2023
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD studyLaura Andreoli, Daniele Lini, Karen Schreiber, et al.
Arthritis Care & Research|September 5, 2023
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?Elisabeth Deibel, Patricia E Carreira, Madelon Vonk, et al.
Journal of Clinical Medicine|May 17, 2020
Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD RegistryHarald Kaemmerer, Matthias Gorenflo, Dörte Huscher, et al.
Rheumatology (Oxford, England)|December 6, 2017
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational StudySébastien Peytrignet, Christopher P Denton, Mark Lunt, et al.
Annals of the Rheumatic Diseases|February 12, 2017
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)Ariane L Herrick, Xiaoyan Pan, Sébastien Peytrignet, et al.
Autoimmunity Reviews|July 28, 2024
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensusPiero Ruscitti, Yannick Allanore, Chiara Baldini, et al.
Annals of the Rheumatic Diseases|August 25, 2017
Mapping and predicting mortality from systemic sclerosisMuriel Elhai, Christophe Meune, Marouane Boubaya, et al.
Annals of the Rheumatic Diseases|January 8, 2018
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational StudyAriane L Herrick, Sebastien Peytrignet, Mark Lunt, et al.
Pageof 63

Showing results (611-620 of 622) with videos related to

Sort By:
Pageof 63
Rheumatology (Oxford, England)|February 3, 2023
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveysParikshit Sen, Naveen R, Nazanin Houshmand, et al.
Rheumatology (Oxford, England)|April 21, 2023
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveysNaveen R, Parikshit Sen, Zoltán Griger, et al.
Rheumatology (Oxford, England)|July 28, 2023
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD studyLaura Andreoli, Daniele Lini, Karen Schreiber, et al.
Arthritis Care & Research|September 5, 2023
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?Elisabeth Deibel, Patricia E Carreira, Madelon Vonk, et al.
Journal of Clinical Medicine|May 17, 2020
Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD RegistryHarald Kaemmerer, Matthias Gorenflo, Dörte Huscher, et al.
Rheumatology (Oxford, England)|December 6, 2017
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational StudySébastien Peytrignet, Christopher P Denton, Mark Lunt, et al.
Annals of the Rheumatic Diseases|February 12, 2017
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)Ariane L Herrick, Xiaoyan Pan, Sébastien Peytrignet, et al.
Autoimmunity Reviews|July 28, 2024
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensusPiero Ruscitti, Yannick Allanore, Chiara Baldini, et al.
Annals of the Rheumatic Diseases|August 25, 2017
Mapping and predicting mortality from systemic sclerosisMuriel Elhai, Christophe Meune, Marouane Boubaya, et al.
Annals of the Rheumatic Diseases|January 8, 2018
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational StudyAriane L Herrick, Sebastien Peytrignet, Mark Lunt, et al.
Pageof 63